Triple-negative breast cancer sequencing

NIAID Data Ecosystem2026-05-25 收录

下载链接：

https://www.ncbi.nlm.nih.gov/sra/SRP152502

下载链接

链接失效反馈

官方服务：

资源简介：

Sequencing analysis part of a phosphoproteomics in vivo study for the prediction of the treatment outcome in triple-negative breast cancer

创建时间：

2018-07-19

Triple-negative breast cancer sequencing

Sequencing analysis part of a phosphoproteomics in vivo study for the prediction of the treatment outcome in triple-negative breast cancer

NIAID Data Ecosystem20

Triple-negative breast cancer organoids sequencing

To determine whether the organoids retained the genetic signature of the patient's tissue, whole-exome sequencing (WES) analysis was conducted on both the organoids and the primary tumor tissue.

NIAID Data Ecosystem10

Triple-negative breast cancer RNA sequencing

Fresh tumor biopsies were prospectively obtained from 50 patients diagnosed with clinical stage II-III TNBC defined as ER-, PR-, and HER2-negative. Briefly, frozen tissue samples were washed with cold

NIAID Data Ecosystem00

Triple-negative breast cancer sequencing data

The gene panel contained 27 genes: ARID1A, ATM, ATR, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CHEK2, CTNNB1, FANCA, FANCC, FANCD2, FANCE, FANCF, KRAS, MRE11A, NBN, PALB2, PIK3CA, PPP2R1A, PTEN, RAD50, RAD51,

NIAID Data Ecosystem10

Triple-negative breast cancer sequencing data

NIAID Data Ecosystem00